Verified, source-grounded records

Verified studies for ARA-290

Study records describe published research and its limitations. They do not establish efficacy, safety, or suitability for any use.

Verified study counts

69 current verified studies.

  • Human research: 0
  • In vitro: 0
  • In vivo/preclinical: 0
  • Review/meta-analysis: 0
  • Other: 0
Filter verified studiesReset filters

Current verified studies

Study type: In vivo/preclinical · Status: Citation only

Immunometabolic dysregulation drives selective executive cognitive dysfunction in male db/db mice.

Neurobiology of disease · 2026

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Exploring the Efficacy of the Non-Erythropoietic Chemical sequence ARA 290 on Visuospatial Learning and Cognitive Flexibility in a Mouse Model of Diabetic Vasculopathy

Cerebral Circulation - Cognition and Behavior · 2025

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

ARA290, an alternative of erythropoietin, inhibits activation of NLRP3 inflammasome in schwann cells after sciatic nerve injury.

European journal of pharmacology · 2025

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

ARA290 Attenuates Apical Periodontitis via SIRT1/NF-κB/IL-1β Pathway Modulation.

International dental journal · 2025

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Erythropoietin-derived chemical sequence ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic stroke.

CNS neuroscience & therapeutics · 2024

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Microglial EPOR Contribute to Sevoflurane-induced Developmental Fine Motor Deficits Through Synaptic Pruning in Mice.

Neuroscience bulletin · 2024

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vitro · Status: Citation only

Mechanistic Approach for Protective Effect of ARA290, a Specific Ligand for the Erythropoietin/CD131 Heteroreceptor, against Cisplatin-Induced Nephrotoxicity, the Involvement of Apoptosis and Inflammation Pathways.

Inflammation · 2023

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Nonerythropoietic Erythropoietin Mimetic Chemical sequence ARA290 Ameliorates Chronic Stress-Induced Depression-Like Behavior and Inflammation in Mice.

Frontiers in pharmacology · 2022

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Early monocyte modulation by the non-erythropoietic chemical sequence ARA 290 decelerates AD-like pathology progression.

Brain, behavior, and immunity · 2022

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

A small erythropoietin derived non-hematopoietic chemical sequence reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan.

Frontiers in cardiovascular medicine · 2022

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice.

International journal of molecular sciences · 2021

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Multifaceted roles of a bioengineered nanoreactor in repressing radiation-induced lung injury.

Biomaterials · 2021

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Synthesis and evaluation ofTc-DOTA-ARA-290 as potential SPECT tracer for targeting cardiac ischemic region.

Iranian journal of basic medical sciences · 2021

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Assessment of the Nephroprotective Properties of the Erythropoietin Mimetic Chemical sequence and Infliximab in Kidney Ischemia-Reperfusion Injury in Rats.

Archives of Razi Institute · 2021

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand.

Transplantation · 2020

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: Human research · Status: Citation only

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

Journal of clinical medicine · 2020

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vitro · Status: Citation only

An engineered non-erythropoietic erythropoietin-derived chemical sequence, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress.

Toxicology in vitro : an international journal published in association with BIBRA · 2020

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Technetium-99 m-PEGylated dendrimer-G-(Dabcyle-Lys,Phe)-pHBSP: A novel Nano-Radiotracer for molecular and early detecting of cardiac ischemic region.

Bioorganic chemistry · 2020

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

Erythropoietin Mimetic Chemical sequence (pHBSP) Corrects Endothelial Dysfunction in a Rat Model of Preeclampsia.

International journal of molecular sciences · 2020

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation only

The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic.

Experimental eye research · 2019

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

  • ARA-290: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation only. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.